home / stock / vnda / vnda articles

VNDA Articles, Vanda Pharmaceuticals Inc.

Stock Information
Company Name: Vanda Pharmaceuticals Inc.
Stock Symbol: VNDA
Market: NASDAQ
Website: vandapharma.com
Menu
VNDA VNDA Quote VNDA Short VNDA News VNDA Articles VNDA Message Board
Get VNDA Alerts

News, Short Squeeze, Breakout and More Instantly...
What's Going On With Vanda Pharmaceuticals Shares Today? | Benzinga

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) shares are trading lower after Future Pak withdrew its proposal to purchase the company. “Consistent...
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

Shares of Jabil Inc. (NYSE:JBL) fell sharply during Thursday's session following third-quarter results. Jabil reported third-quarter fiscal 20...

Why Vuzix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of Vuzix Corporation (NASDAQ:VUZI) rose sharply in today's pre-market trading after the company disclosed a strategic partnership with ...

Vanda Pharmaceuticals And Other Big Stocks Moving Lower In Thursday's Pre-Market Session | Benzinga

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 100 points on Thursday. Shares of Vanda Pharmaceuticals Inc. (N...
Tesla, Nvidia, John Wiley & Sons And Other Big Stocks Moving Higher On Thursday | Benzinga

U.S. stocks were mixed, with the Dow Jones index falling around 200 points on Thursday. Shares of Tesla Inc (NASDAQ:TSLA) rose sharply during Thurs...

Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

Shares of G-III Apparel Group, Ltd. (NASDAQ:GIII) fell sharply during Thursday's session after the company reported worse-than-expected quarte...

Crude Oil Jumps 2%; Lululemon Posts Upbeat Earnings | Benzinga

U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining around 50 points on Thursday. The Dow traded up 0.14% to 38,860.4...
Vanda Pharmaceuticals Receives Another Takeover Proposal, Considers $466M Deal | Benzinga

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) received an acquisition offer from Cycle Pharmaceuticals Ltd worth $8 per share, representing a total cash...

Exact Sciences Reports Q1 Loss, Joins Beyond Meat, Duolingo And Other Big Stocks Moving Lower In Thursday's Pre-Market Session | Benzinga

U.S. stock futures were lower this morning, with the Dow futures falling around 100 points on Thursday. Shares of Exact Sciences Corporation (NASDA...

US Supreme Court Declines To Hear Vanda Pharmaceuticals' Case Regarding Invalidation Of Patents For Its Sleep Disorder Drug, Hetlioz | Benzinga

The U.S. Supreme Court has reportedly chosen not to review Vanda Pharmaceuticals Inc’s (NASDAQ:VNDA) attempt to revive patents...
Next 10